Fifth Third Bancorp
PMD

Fifth Third Bancorp’s Psychemedics Corporation PMD Stock Holding History

Fifth Third Bancorp’s Portfolio PMD Stock Details PMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-300
Closed -$5K – 2331
2018
Q4 		$5K Hold
300
– – ﹤0.01% 1985
2018
Q3 		$6K Hold
300
– – ﹤0.01% 1964
2018
Q2 		$6K Hold
300
– – ﹤0.01% 2018
2018
Q1 		$6K Hold
300
– – ﹤0.01% 2034
2017
Q4 		$6K Hold
300
– – ﹤0.01% 1973
2017
Q3 		$6K Hold
300
– – ﹤0.01% 1913
2017
Q2 		$7K Hold
300
– – ﹤0.01% 1835
2017
Q1 		$6K Buy
+300
New +$6.59K ﹤0.01% 1826

Other funds holding PMD

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CIC
Crawford Investment Counsel Atlanta, Georgia $5.85B AUM 12.61% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DRZID
DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.29B AUM 20.14% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Fifth Third Bancorp's PMD Position: Q1 2019 in Review

Fifth Third Bancorp sold out of Psychemedics Corporation (PMD) in Q1 2019, closing a stake of 300 shares — an estimated $5K sold.

Fifth Third Bancorp first reported a position in PMD in Q1 2017 and held it in 8 quarters. The position peaked at $7K in Q2 2017. 52 funds tracked by Wall St. Rank hold PMD as of Q1 2019.

  • Fifth Third Bancorp reported no remaining Psychemedics Corporation position as of Q1 2019 after selling out during the quarter.
  • Fifth Third Bancorp sold 300 Psychemedics Corporation shares in Q1 2019, an estimated $5K.
  • Fifth Third Bancorp first reported a position in Psychemedics Corporation in Q1 2017 and held it in 8 quarters.
  • Fifth Third Bancorp's Psychemedics Corporation position peaked at $7K in Q2 2017.
  • 52 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q1 2019.

Based on Fifth Third Bancorp's 13F filing for Q1 2019, filed 14 May 2019.